Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-049911
Filing Date
2021-08-05
Accepted
2021-08-05 16:01:54
Documents
2
Period of Report
2021-08-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1577
2 POA DOCUMENT poa.txt EX-24.3_1002333 3848
  Complete submission text file 0001209191-21-049911.txt   6863
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address
Xu Yuan (Reporting) CIK: 0001858214 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36076 | Film No.: 211148051